Medplus Health Services Limited

70%

.Safe Harbour1 The MedPlus StoryOverview228k+ EmployeesStore level Unit economics with ROCE of over 70%~1,290 Outlets which are < 24M, upon maturity are P&L accretiveServing the Customers of ~800 CitiesW

₹ 68,925

ster based expansion strategy: ‘Continue deeper penetration vs. Wider reach’Q4FY26 FY2026 Highlights₹ 68,925m Revenue•₹ 7,564m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,0

₹ 7,564

on strategy: ‘Continue deeper penetration vs. Wider reach’Q4FY26 FY2026 Highlights₹ 68,925m Revenue•₹ 7,564m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•

12.3%

penetration vs. Wider reach’Q4FY26 FY2026 Highlights₹ 68,925m Revenue•₹ 7,564m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•26.2% GM%, increased by 180

2.6%

. Wider reach’Q4FY26 FY2026 Highlights₹ 68,925m Revenue•₹ 7,564m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•26.2% GM%, increased by 180 bps over FY25

₹ 18,079

68,925m Revenue•₹ 7,564m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•26.2% GM%, increased by 180 bps over FY25618 Store Net Additions•792 gross additions•

26.2%

m increase over FY25, 12.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•26.2% GM%, increased by 180 bps over FY25618 Store Net Additions•792 gross additions•384 net additions be

180 bps

.3% increase•2.6% increase in private label over FY25₹ 18,079m Gross Margin•26.2% GM%, increased by 180 bps over FY25618 Store Net Additions•792 gross additions•384 net additions beyond Tier-OneStores > 12 m

9.4%

FY25618 Store Net Additions•792 gross additions•384 net additions beyond Tier-OneStores > 12 months•9.4% revenue growth over FY25•11.9% Store Level EBITDA margin₹ 3,476m Pharmacy Operating EBITDA •5.1% Op

11.9%

2 gross additions•384 net additions beyond Tier-OneStores > 12 months•9.4% revenue growth over FY25•11.9% Store Level EBITDA margin₹ 3,476m Pharmacy Operating EBITDA •5.1% Operating EBITDA margin in Pharma

₹ 3,476

ions beyond Tier-OneStores > 12 months•9.4% revenue growth over FY25•11.9% Store Level EBITDA margin₹ 3,476m Pharmacy Operating EBITDA •5.1% Operating EBITDA margin in Pharmacy •₹ 3,658m Company Operating EB

5.1%

hs•9.4% revenue growth over FY25•11.9% Store Level EBITDA margin₹ 3,476m Pharmacy Operating EBITDA •5.1% Operating EBITDA margin in Pharmacy •₹ 3,658m Company Operating EBITDA ₹ 917m Operating Cash Flow•8